| Authors | Jeff P Sharman, Miklos Egyed, Wojciech Jurczak, Alan Skarbnik, John M Pagel, Ian W Flinn, Manali Kamdar, Talha Munir, Renata Walewska, Gillian Corbett, Laura Maria Fogliatto, Yair Herishanu, Versha Banerji, Steven Coutre, George Follows, Patricia Walker, Karin Karlsson, Paolo Ghia, Ann Janssens, Florence Cymbalista, Jennifer A Woyach, Emmanuelle Ferrant, William G Wierda, Veerendra Munugalavadla, Ting Yu, Min Hui Wang, John C Byrd |
| Journal | Leukemia
(Leukemia)
Vol. 36
Issue 4
Pg. 1171-1175
(04 2022)
ISSN: 1476-5551 [Electronic] England |
| PMID | 34974526
(Publication Type: Research Support, Non-U.S. Gov't, Letter)
|
| Chemical References |
- Antibodies, Monoclonal, Humanized
- Benzamides
- Pyrazines
- Chlorambucil
- acalabrutinib
- obinutuzumab
|
| Topics |
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects)
- Benzamides
- Chlorambucil
(therapeutic use)
- Follow-Up Studies
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell
(drug therapy)
- Pyrazines
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|
